Covid-19: Pfizer working on vaccine targeting Delta variant, clinical trials to start August

9/7/2021 9:41:00 AM

Covid-19: Pfizer working on vaccine targeting Delta variant, clinical trials to start August

Covid-19 Watch, Covid-19

Covid-19 : Pfizer working on vaccine targeting Delta variant, clinical trials to start August

CHICAGO, United States (Bernama): Drugmaker Pfizer-BioNTech announced Thursday (July 8) that it is working on a Covid-19 vaccine to target the Delta variant and will begin clinical trials in August in case it is needed.

But Pfizer pointed to the situation in Israel – the nation saw an earlier and more effective vaccine rollout than in many other countries. Seven months later, however, vaccine effectiveness appeared to be waning as the Delta variant spread and the Israeli government reinstating an indoor mask mandate.

Pfizer-BioNTech is also asking the US FDA to approve their new Covid-19 booster shot, which they say will increase protection against the virus.According to Anadolu Agency (AA), the companies started researching the effectiveness of a third booster shot back in February, as a way to protect against possible variants of Covid-19.

Read more:
The Star »

Muhyiddin says Perikatan never received election funding from gaming companies

KULIM: Perikatan Nasional denies receiving funds from gaming companies to cover campaigning costs during the 15th General Election (GE15). Read more >>

No ending to vaccinations. Makes one wonder if C19 is manmade

Covid-19: Delta variant detected in SarawakThis is the first positive case involving the Delta variant detected in Sarawak in a recent genome sequencing analysis.

Covid-19 Delta variant detected in Sarawak, says Unimas’ health institute | Malay MailKUCHING, July 8 — The first Covid-19 positive case involving the Delta variant in Sarawak has been detected, according to the Institute of Health and Community Medicine (IHCM) of Universiti Malaysia Sarawak (Unimas). According to IHCM in a statement today, the variant was detected following its...

Covid-19: Delta variant detected in SarawakKUCHING (Bernama): The first Covid-19 case involving the Delta variant in Sarawak has been detected, according to the Institute of Health and Community Medicine (IHCM) of Universiti Malaysia Sarawak (Unimas). Oh no

Covid-19: Active cases continue to rise - 7,097 today | New Straits TimesKUALA LUMPUR: The number of active Covid-19 cases continue to climb with more new cases recorded against the number of recoveries as of noon today.

Minister: Covid-19 vaccination for frontliners in retail, distribution sector expected next week | Malay MailBENTONG, July 7 — Almost 500,000 frontliners in the retail and distribution sector are expected to receive their Covid-19 vaccines next week, says Domestic Trade and Consumer Affairs Minister Datuk Seri Alexander Nanta Linggi. He said details of the programme are being finalised and vaccination...

Indonesia's tourism recovery on hold amid Covid-19 outbreakJAKARTA (Xinhua): The re-opening of Indonesia's holiday islands to international tourists still seems like a long shot.

Some industry experts have warned that profit could be more a motivating factor for drug companies eager to get new vaccines approved by the US Food and Drug Administration (FDA).The first Covid-19 positive case involving the Delta variant in Sarawak has been detected, according to the Institute of Health and Community Medicine (IHCM) of Universiti Malaysia Sarawak (UNIMAS).Telegram channel for the latest updates.According to IHCM in a statement Thursday (July 8), the variant was detected following its genome sequencing analysis recently.

But Pfizer pointed to the situation in Israel – the nation saw an earlier and more effective vaccine rollout than in many other countries. Seven months later, however, vaccine effectiveness appeared to be waning as the Delta variant spread and the Israeli government reinstating an indoor mask mandate.. Pfizer-BioNTech is also asking the US FDA to approve their new Covid-19 booster shot, which they say will increase protection against the virus. “A 56-year-old man has been detected with the variant on June 18 and his case is classified as Import B case,” it said. According to Anadolu Agency (AA), the companies started researching the effectiveness of a third booster shot back in February, as a way to protect against possible variants of Covid-19.. The booster shot they have come up with does not specifically target any Covid-19 variant, and US health officials have already said that the current vaccines on the market protect against the surging Delta variant. It was tasked with testing samples and genome sequencing analyses to detect changes in the virus.

However, Pfizer-BioNTech say they have seen"encouraging data" that their booster shot, in general, provides more effective protection when administered within six months after the second dose. Since the outbreak of Covid-19 last year, IHCM has been at the forefront of the fight against the pandemic in the state. In the United States, the problem remains, vaccine hesitancy colliding with the Delta variant, which may be more transmissible and more dangerous. Virtually, all of the Covid-19-related deaths recorded in the US now are people who did not get any vaccine, and the Delta variant has become the dominant strain in the country. The director of the Centres for Disease Control and Prevention said Thursday that the United States is becoming highly fractured, with many parts of the country so well-protected from the virus that Covid-19 deaths have all but vanished. But in pockets of the country, specifically in the South and Midwest, Covid-19 cases have spiked so much recently that some hospitals have had to turn patients away and put calls out for extra ventilators.

– Bernama Article type: metered .